Physician profile
Siham Gellani
NPI 1700426616
$3,902.86
in general payments reported to CMS, 2019-2025
32 companies · $545 in 2025
The $545 reported for 2025 was more than what 96% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $822 · 2022: $919 · 2023: $855 · 2024: $762 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,161.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $643.13 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $398.92 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $386.64 | 2021-2022 | |
| Organon LLC | $306.92 | 2021-2025 | Nexplanon, Nuvaring |
| Aspira Women'S Health INC | $283.74 | 2021-2025 | Ova1 |
| Pfizer INC. | $247.41 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $190.09 | 2021-2024 | Xifaxan |
| Exeltis, USA INC. | $170.43 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $162.69 | 2021-2025 | |
| Agile Therapeutics, INC. | $104.03 | 2021-2023 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $98.45 | 2021-2025 | |
| Lilly USA, LLC | $95.76 | 2025 | Zepbound |
| Daiichi Sankyo INC. | $94.11 | 2022-2025 | Injectafer |
| Hologic Sales and Service, LLC | $80.60 | 2023-2025 | Myosure Tissue Removal Device, Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $69.62 | 2024-2025 | Veozah |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $61.80 | 2022 | |
| Coopersurgical, INC. | $58.07 | 2022-2025 | Paragard T 380a |
| Exact Sciences Corporation | $55.25 | 2023-2025 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $49.75 | 2022 | |
| Millicent US INC | $46.56 | 2024-2025 | Intrarosa, Femring |
| Seqirus USA INC | $39.32 | 2024-2025 | Flucelvax, Fluad |
| Amgen INC. | $37.84 | 2021-2024 | Prolia, Evenity |
| Mylan Pharmaceuticals INC. | $31.05 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $30.27 | 2021-2022 | |
| Avion Pharmaceuticals | $27.67 | 2021-2023 | Balcoltra |
| Dexcom, INC. | $26.14 | 2024 | Dexcom G6 Transmitter |
| Sage Therapeutics, LLC | $25.46 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $20.19 | 2024 | Gardasil, Gardasil 9 |
| Medicem INC. | $15.97 | 2023 | |
| Channel Medsystems, INC. | $15.93 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $15.88 | 2023 | Exparel |
| Kci USA, INC. | $13.17 | 2023 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Siham Gellani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.